Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions

AimsAntibodies against phosphorylcholine (anti-PC) are implicated as protection markers in atherosclerosis, cardiovascular disease (CVD), and other chronic inflammatory conditions. Mostly, these studies have been focused on IgM. In this study, we determined IgG, IgG1, and IgG2 anti-PC among 60-year-...

Full description

Bibliographic Details
Published in:Frontiers in Cardiovascular Medicine
Main Authors: Shailesh Kumar Samal, Pritam Kumar Panda, Max Vikström, Karin Leander, Ulf de Faire, Rajeev Ahuja, Johan Frostegård
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.809007/full